Advertisement
Screener

Advanced Biomed Inc (ADVB) Graph

ADVB Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-03-31: Research and development $243.23K; Operating expenses $519.84K; Net income -$488.94K.
  • 2025-12-31: Research and development $186.33K; Operating expenses $396.64K; Net income $6.86M.
  • 2025-09-30: Research and development $235.99K; Operating expenses $523.91K; Net income -$386.90K.
  • 2025-03-31: Research and development $219.97K; Operating expenses $567.51K; Net income -$1.38M.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endResearch and developmentOperating expensesNet income
2026-03-31$243.23K$519.84K-$488.94K
2025-12-31$186.33K$396.64K$6.86M
2025-09-30$235.99K$523.91K-$386.90K
2025-03-31$219.97K$567.51K-$1.38M
2024-12-31$212.40K$280.06K-$907.90K
2024-09-30$181.70K$520.03K-$265.58K
2024-03-31$313.51K$745.41K-$1.06M
2023-12-31$188.39K$651.30K-$145.34K

Revenue and expense 6 month

Period endResearch and developmentOperating expensesNet income
2025-12-31$421.91K$791.52K$6.47M
2024-12-31$380.09K$507.64K-$1.17M
2023-12-31$357.57K$1.09M-$916.66K

Revenue and expense 9 month

Period endResearch and developmentOperating expensesNet income
2026-03-31$665.14K$1.31M$5.98M
2025-03-31$600.06K$1.08M-$2.56M
2024-03-31$671.08K$1.84M-$1.97M

Revenue and expense 12 month

Period endResearch and developmentOperating expensesNet income
2025-06-30$909.77K$3.02M-$3.26M
2024-06-30$880.19K$2.54M-$2.78M

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45